Glendora, CA, United States of America

Michael Burkhart


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Burkhart: Innovator in Aqueous Ifosfamide Composition

Introduction

Michael Burkhart is a notable inventor based in Glendora, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on aqueous ifosfamide compositions. His expertise and dedication to research have led to the development of a unique formulation that enhances the usability of ifosfamide in medical applications.

Latest Patents

Michael Burkhart holds 1 patent for his invention titled "Aqueous Ifosfamide Composition." This invention is directed towards a ready-to-use aqueous composition of ifosfamide. In one embodiment, the invention comprises ifosfamide, a pharmaceutically acceptable buffer, and water. The concentration of ifosfamide in the composition may range between about 40 mM and about 400 mM. Additionally, the concentration of buffer in the composition may vary between about 10 mM and about 260 mM. The molar ratio of ifosfamide to buffer can be between about 0.5:1 to about 20:1, with the pH of the composition maintained between about 4 and about 8.

Career Highlights

Michael Burkhart is associated with Gensia Sicor Pharmaceuticals, Inc., where he has contributed to various projects and innovations. His work has been instrumental in advancing pharmaceutical formulations, particularly in the area of cancer treatment.

Collaborations

Michael has collaborated with various professionals in his field, including his coworker Dorla Mirejovsky. Their combined efforts have fostered a productive environment for innovation and development in pharmaceutical sciences.

Conclusion

Michael Burkhart's contributions to the field of pharmaceuticals, particularly through his patent on aqueous ifosfamide composition, highlight his role as an innovator. His work continues to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…